Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29546259

NC(=O)c1nnc(C2CCNC2)o1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.34
MPO P05164 1/20 0.34
HRH4 Q9H3N8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
SCD O00767 1/20 0.32
TLR9 Q9NR96 3/20 0.31
TLR8 Q9NR97 3/20 0.31
TLR7 Q9NYK1 3/20 0.31
HTR4 Q13639 1/20 0.30
JAK3 P52333 1/20 0.30
NOTUM Q6P988 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30
CHRNB3 Q05901 1/20 0.30
CHRNA6 Q15825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29546533 0.91 PARP1 (0.39) PARP1MPOTLR9TLR8TLR7
SCHEMBL6431313 0.74 CA1 (0.38)
Trifluoroacetic Acid SCHEMBL29545865 0.73 CHRNB2 (0.32) SCDCHRNB2CHRNA3CHRNA4CHRNB3
Trifluoroacetic Acid SCHEMBL27195372 0.73 PDK2 (0.37) HTR4
Trifluoroacetic Acid SCHEMBL30848776 0.70 CHRNA7 (0.34)
SCHEMBL12255455 0.69 MPO (0.43) MPOTLR9TLR8TLR7
Trifluoroacetic Acid SCHEMBL23779156 0.68 KDM4E (0.58) PARP1
Trifluoroacetic Acid SCHEMBL30478376 0.68 KDM4E (0.58) PARP1
Trifluoroacetic Acid SCHEMBL3450626 0.68 KDM4E (0.58) PARP1
Trifluoroacetic Acid SCHEMBL27034351 0.67 HRH4 (0.36) HRH4HRH3JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4157834-A1 N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION Mission Therapeutics Limited (GB) 2023-04-05 EP disclosed
WO-2022084479-A1 N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS MISSION THERAPEUTICS LIMITED (GB) 2022-04-28 WO disclosed